Carmofur

卡莫氟

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarmofur
Drug Alias Name孚贝Carmofurum密福禄氟己嘧啶氟脲己胺 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsStomach NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4] 
Global Approved IndicationsStomach NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4] 
Approved Indications in ChinaStomach NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4] 
Original Approved Country/TerritoryJapan
Original Approved Date1981/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesQilu Tianhe Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsColorectal NeoplasmsEsophageal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL01BC04
Related LinksWikipediaDrugBankKEGG